Date | Company | Round | Amount | Co-investors |
---|---|---|---|---|
2013-05-13 | Gliknik | Series B - II | $16.1M | Baxter Ventures, and Joel B. Braunstein |
2012-10-08 | Gliknik | Series B | $4.9M | Baxter Ventures, and Joel B. Braunstein |
2011-09-20 | Gliknik | Series A - IV | $2.03M | Joel B. Braunstein |
2010-06-18 | Gliknik | Series A - III | $2.4M | |
2010-06-17 | Corridor Pharmaceuticals | Series A | $15M | Acidophil, Ben Franklin Technology Partners of Southeastern PA, Domain Associates, MedImmune Ventures, NewSpring Capital, Quaker BioVentures, and Red Abbey Venture Partners |